# Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer

> **NCT07753499** · NA · RECRUITING · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 120 (estimated)

## Conditions studied

- Tumor
- Solid Tumor
- Thyroid Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Compared the diagnostic performance of 68Ga-MY6349 PET/CT with 68Ga-FAPI PET/CT

## Key facts

- **NCT ID:** NCT07753499
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07753499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07753499, "Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07753499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*